Targeted gold nanoparticles for ovarian cancer (Review)

Wenjuan He1, Fuyuan Yang2, Keming Chen1

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei 434000, P.R. China.

Oncology Letters
|October 17, 2024
PubMed

Insights

Gold nanoparticles (AuNPs) show promise for ovarian cancer (OC) therapy. Research focuses on AuNP synthesis and functionalization for targeted drug delivery and photothermal treatment, aiming for earlier and more effective OC interventions.

Area of Science:

  • Nanotechnology
  • Oncology
  • Materials Science

Background:

  • Ovarian cancer (OC) presents a high mortality rate among gynecological malignancies.
  • Late-stage diagnosis often limits treatment efficacy and curability.
  • Early detection is crucial for personalized and optimized therapeutic strategies.

Purpose of the Study:

  • To review the synthesis and characteristics of gold nanoparticles (AuNPs).
  • To explore the potential applications of AuNPs in ovarian cancer (OC) therapy.
  • To highlight AuNPs as innovative materials for biological and photothermal treatments.

Main Methods:

  • Summarizing existing research on AuNP synthesis and characterization.
  • Discussing the chemical modification and functionalization of AuNPs.
  • Reviewing studies on AuNP applications in OC treatment strategies.

Main Results:

  • Gold nanoparticles (AuNPs) can be synthesized and chemically modified for specific applications.
  • AuNPs demonstrate suitability as carriers for targeted drug delivery systems.
  • Functionalized AuNPs offer potential for innovative photothermal therapies in OC treatment.

Conclusions:

  • Gold nanoparticles (AuNPs) represent a promising platform for advancing ovarian cancer (OC) diagnostics and therapeutics.
  • Further research into AuNP functionalization can enhance targeted drug delivery and photothermal efficacy.
  • AuNPs hold significant potential for improving outcomes in ovarian cancer (OC) management.